Vaccine advances Amid Political Headwinds

A paradox of today’s era is that, from gene editing to space research to computing, the world is living through a golden age of science, but a dispiriting one in politics – which, notably in the US, can jeopardise scientific progress. Nowhere is that more true than with vaccines.

This year has been good for vaccine science. New immunisations have continued to be deployed against diseases that for years were tricky targets. Two major vaccines against chikungunya, a mosquito-borne virus that can cause painful symptoms, have received international approvals. Two vaccines approved in the past four years against malaria – which still kills more than half a million mostly children a year – are being rolled out at record speed.

Simultaneously occurring, mRNA technology, the breakthrough that powered two of the main Covid-19 vaccines, is being used in new ways. The UK and Switzerland this year became the latest countries to approve the first non-Covid mRNA vaccine, pfizer’s vaccine against respiratory syncytial virus (RSV), which can be hazardous for infants and older adults.

Yet, despite these advances, vaccine confidence is waning in some parts of the world.The US,in particular,has seen a rise in vaccine hesitancy,fuelled by misinformation and political polarisation. This poses a notable threat to public health, as lower vaccination rates can lead to outbreaks of preventable diseases.

The politicisation of vaccines is deeply concerning. Vaccines are a cornerstone of modern medicine, and their success relies on widespread public trust. When vaccines become a political issue, it undermines that trust and puts lives at risk. Funding for vaccine research and development is also vulnerable to political shifts, creating uncertainty for scientists and hindering progress.

Looking ahead, maintaining momentum in vaccine development will require a concerted effort to address vaccine hesitancy and ensure stable funding for research. This includes combating misinformation, building trust with communities, and advocating for policies that support vaccine access and innovation. The future of public health depends on it.

Key Takeaways

• Significant advancements in vaccine technology are occurring, with new immunizations for diseases like chikungunya, malaria, and RSV.
• mRNA technology, proven effective during the covid-19 pandemic, is now being applied to other vaccines.
• Vaccine confidence is declining in some regions, particularly the US, due to misinformation and political polarization.
• Politicization of vaccines threatens public health and can disrupt funding for crucial research.
• Addressing vaccine hesitancy and securing consistent research funding are vital for future progress.

Publication Date: 2025/12/10 18:45:18